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Abstract 
Intracellular signalling is critically dependent on gene regulatory networks comprising 
physical molecular interactions. Presently, there is a lack of comprehensive databases for 
most human tissue types to verify such macromolecular interactions. We present a user 
friendly browser which helps to identify functional macromolecular interactions in human 
bone as significant correlations at the transcriptional level. The molecular skeletal phenotype 
has been characterized by transcriptome analysis of iliac crest bone biopsies from 84 
postmenopausal women through quantifications of ~23000 mRNA species. When the signal 
levels were inter-correlated, an array containing >260 million correlations were generated, 
thus recognizing the human bone interactome at the RNA level. The matrix correlation and p 
values were made easily accessible by a freely available online browser. We show that 
significant correlations within the giant matrix are reproduced in a replica set of 13 male 
vertebral biopsies. The identified correlations differ somewhat from transcriptional 
interactions identified in cell culture experiments and transgenic mice, thus demonstrating that 
care should be taken in extrapolating such results to the in vivo situation in human bone.  
The current giant matrix and web browser is a valuable tool for easy access to the 
human bone transcriptome and molecular interactions represented as significant correlations 
at the RNA-level. The browser and matrix should be a valuable hypothesis generating tool for 
identification of regulatory mechanisms and serve as a library of transcript relationships in 
human bone, a relatively inaccessible tissue. 
 
Keywords: human, bone biopsies, expression profiling, browser, correlation, 
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1. Introduction 
The regulation of gene expression in complex organisms relies on functional cohorts of 
macromolecules, including transcription factors (TFs), chromatin modulators, RNA 
enzymes/splicing RNAs, microRNAs and other non-coding RNAs. A part of this complex 
machinery consists of inducer and suppressive TFs whose actions are mediated by enhancer 
elements containing multiple, but distinct TF binding sites scattered over distances of roughly 
100 kb in mammals [1]. Moreover, TFs interact with other signaling molecules that inhibit or 
induce transcription. The molecular mechanisms involved in the over-all regulation of 
transcription remain as one of the most challenging problems in molecular biology.  
 The identification of highly correlated transcripts in bone is likely a valuable 
hypothesis generating tool, since they are expected to be similarly regulated and/or involved 
in the same signaling pathways [2,3]. These associated transcripts may help to identify novel 
TFs, and their gene targets of importance for bone metabolism. A previous study of 3 datasets 
of gene expression in immortalized B cells from normal individuals showed that correlations 
in expression levels could be used to predict gene function [4]. Software analyzing molecular 
interactions have been made to explore the complex biology of expression data as well as 
signifying highly correlating transcripts, e.g. [5-7]. However, they have various shortcomings, 
such as not being user friendly as the dataset intended for study must be normalized, uploaded 
and then specifically adapted to the program [5]. Another program enables online 
identification of positively or negatively correlating pairs of microRNAs and mRNAs in large 
datasets, but does not detect correlating pairs of mRNAs [6]. In a third alternative program the 
correlations can not be restricted to bone and neither p-values nor adjusted p-values are 
calculated [7]. 
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 We have performed global correlation analysis on transcription profiles from trans-iliacal 
bone biopsies of post menopausal women aiming at detecting biological meaningful 
interactions. Trans-iliacal bone biopsies is of particular value as they represent a complex and 
rather inaccessible tissue comprising precursor and mature normal bone cells; osteocytes, 
osteoblasts and osteoclasts, as well as populations of multipotent immunological and 
hematological mesenchymal stem cells at different stages of differentiation. Based on the 
global correlation matrix for bone, we developed a web-based online browser that can be used 
to explore correlations for specific genes of interest in human bone.    
 We show that the current giant matrix and web browser appear to be a valuable tool 
for exploring various transcriptional regulations experimentally documented as interactions at 
the macromolecular levels and provides easy and unique access to the human bone 
transcriptome.  
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2. Materials and methods 
2.1. Bone donors and biopsies 
Norwegian women (50–86 years) representing a cohort with varying bone mineral densities 
(BMDs) and free of primary diseases known to affect the skeleton were consecutively 
recruited at the Lovisenberg Deacon Hospital, the Out-patient Clinic, Oslo [8]. Briefly, out of 
301 registered women two thirds were rejected due to medication or secondary diseases other 
than primary postmenopausal osteoporosis that could affect bone metabolism. Thus, 84 trans-
iliacal bone biopsies were obtained from os ileum at the same location (2.0 cm from crista 
iliaca and 2 cm from spina iliaca). All bone biopsies were performed in the morning on 
fasting individuals [9]. The biopsies were cylindrical, 0.8 cm in diameter with average length 
of about 1.5 cm. Connective tissue and muscle were removed before freezing in liquid 
nitrogen. For the replica study, 13 bone biopsies from vertebral lamina were obtained from 
British Caucasian males as described [10]. 
 
2.2. RNA purification and gene expression analysis 
Total RNA was purified and subjected to analysis on HG-U133 plus 2.0 chips (Affymetrix) as 
described [8]. 
Reproducibility of the analysis on HG-U133 plus 2.0 chips was controlled by TaqMan 
Gene Expression analysis (real-time RT-PCR validation) (Applied Biosystems) of 21 selected 
transcripts according to the manufacturer’s instructions with the ribosomal protein L41 
(RPL41) as internal standard [8]. The data for postmenopausal biopsies have been submitted 
to the European Bioinformatics Institute (EMBL-EBI) ArrayExpress repository, ID: E-
MEXP-1618, while the data on male biopsies are accessible from the same site through 
accession number: E-MEXP-2219. 
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2.3. Ethics 
Prior to the study, validation and recommendation were obtained by the Norwegian and 
Northumberland Local Research Ethics Committees (REK 2010/2539 and REC 04/Q0902/29, 
respectively). All sampling and procedures followed the law in both countries, and all subjects 
gave their informed written consent. 
 
2.4. Calculations, statistics and the web application 
Pearson product-moment correlation coefficients (r) were computed between expressions of 
all genes (~23 000 probesets) across 84 women using log transformed signal values and saved 
in a database along with their corresponding p-values. A web application publicly available at 
http://app.uio.no/med/klinmed/correlation-browser/iliac-v1.1/ was programmed in order to 
access the database and flexibly search for correlations of interest. Search results are returned 
together with raw and Bonferroni-corrected p-values and a measure of the false discovery rate 
(FDR) as estimated by the Benjamini & Hochberg procedure [11]. This procedure has been 
shown to control FDR when the tests are independent or positively correlated [12], a 
reasonable assumption when identifying differentially expressed genes. The browser program 
is further described in the Supplementary. 
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3. Results 
3.1. Expressional profiling and web application 
Using HG-U133 plus 2.0 microarrays and the Affymetrix MAS 5.0 software, we first 
identified the global human iliac bone transcriptome in 84 postmenopausal women as 
described previously [8]. We then generated matrixes of all ~23000 by ~23000 pairwise 
Pearson correlations and their corresponding p-values using the statistics package R. A web 
application, the correlation browser, was created to facilitate the assessment of specific and 
significant associations within this matrix. It is publicly available at 
http://app.uio.no/med/klinmed/correlation-browser/iliac-v1.1/ and also calculates Bonferroni 
corrected p-values or FDR q-values as described in Materials and Methods and 
Supplementary. The user interphase of the browser is depicted in Fig. 1.  
 
3.2. Verification of correlations to GR, SMAD4, CREB1 
To test whether gene interactions identified by in-vitro cell culture studies reflected 
correlations in vivo in human bone, we looked for well documented reference studies 
identifying genes directly regulated by specific TFs. We then studied whether the relationship 
between the TFs and their regulated genes were reproduced as significant correlations in our 
giant matrix and in an independent set of male vertebral bone biopsies. Thus, reference 
studies had to be selected that identified TF binding promoter regions and corresponding 
genes. Such studies involve chromosome immunoprecipitation and often additional 
verification by cloning of the identified promoter elements into reporter plasmids, transfection 
of mammalian cells and activation of the regulating TF.  
We selected 3 reference studies that identified a relatively large number of TF target 
genes, and that also were of relevance to bone. These studies identified target genes of the 
TFs glucocorticoid receptor (GR), SMAD4 and CREB1 [13-15]. 
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3.3. Verification of correlations to GR mRNA 
Seventy different genes were identified as GR (encoded by the NR3C1 gene) targets by 
chromosome immunoprecipitation from A549 adenocarcinomic human alveolar basal 
epithelial cells, followed by luciferase assays of the cloned response elements in reporter 
plasmids [13]. Of the 70 genes, promoter elements from 50 and 20 were activated or 
repressed, respectively, upon stimulation of the transfected cells with dexamethasone for GR 
induction. In the iliac bone biopsies, transcripts representing 40 out of the 70 genes reached 
detection level. Our correlation analysis showed that 31 of them (>77 % of those present) 
were significantly (p<0.05) correlated to glucocorticoid receptor mRNA expression levels 
after Bonferroni correction for multiple testing (Table 1). Interestingly, more than half of the 
transcripts (n=21) showed inverse associations (marked as *) as compared to the reference 
study [13]. The iliacal correlation r-values were well reproduced in the male vertebral 
biopsies, with somewhat less significance, probably due to the more limited number of 
samples.  
Furthermore, we made a search for the 50 topmost correlated transcripts to GR in our 
giant matrix. We used the manually curated database of genes containing GR binding 
elements (GREs) from BIOBASE (Biobase, Beverly, MA) (http://biobase-international.com/) 
to identify that 22 out of the 50 topmost GR correlated genes contained GREs (Supplementary 
Table S1).  
 
3.4. Verification of correlations to SMAD4 mRNA 
Qin et al. [14] identified SMAD4 targets in human ovarian surface epithelium by first 
identifying SMAD4 binding promoter elements by Chip-Chip analysis. 150 TGFβ/SMAD 
responsive SMAD4 binding genes were then verified by expression profiling of immortalized 
ovarian surface epithelial (IOSE) cells treated with TGFβ for 0, 3, 6 or 12 hrs. Out of 47 
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genes regulated at two or more different time periods, 38 (> 80%) were correlated to SMAD4 
mRNA levels in the iliac bone biopsies as judged by significant p-values after Bonferroni 
correction for multiple testing (Table 2). The correlation values of the replica male vertebral 
biopsies were in good agreement with those from postmenopausal iliac crest. 
 
3.5. Verification of correlations to CREB1 mRNA 
Many genes contain also CREB1 binding elements in their promoter regions, and thus 
are activated by forskolin via CREB1. A well documented study by Impey et al. [15] was 
selected for evaluation versus the human bone data. The study identified 70 cAMP regulated 
genes that bound CREB1 in their promoter regions. Of these, 37 reached detection level in the 
iliac bone biopsies and 33 (> 89%) were significantly correlated to CREB1 mRNA levels in 
human bone after Bonferroni correction for multiple testing (Table 3). Also here the 
correlation values of the replica male vertebral biopsies were in good agreement with those 
from postmenopausal bone. 
 
3.6. Further controls of the relevance of giant matrix correlations 
More than 95 % of bone cells are osteocytes [16], and analysis of expressional 
correlations after osteocyte specific gene ablation was used as one control. We tested whether 
transcripts that changed expression in 6 week old mice femurs upon osteocyte specific 
ablation of the Pkd1 (polycystic kidney disease 1) gene [17] were reproduced as significant 
correlations in human iliac bone. Significant correlations were obtained for all of the 7 
mRNAs that reached detection levels in the human biopsies (those encoded by SOST, SPP1, 
DMP1, MMP13, IBSP, BGLAP and RUNX2). Of these SOST and SPP1 showed similar 
correlations as found in mice, while the rest was inversely correlated (data not shown).  
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Fig. 1 identifies the transcripts most significantly correlating to SOST mRNA having 
“transcription” as GO keyword. The resulting list of topmost SOST associations represents 
mostly mRNAs of genes involved in transcriptional regulation of SOST. Several of these are 
known to regulate SOST transcription. RUNX2 binds to response elements in the SOST 
promoter [18]. SATB2 may also be listed as a SOST regulating transcription factor as it 
interacts with and enhance the activity of RUNX2 [19]. Furthermore, all but 3 of the 9 
different transcripts most significantly correlated to SOST mRNA (Fig. 1) are known to be 
related to the Wnt signaling pathway (SFRP4, DVL3) and/or osteoblast 
development/differentiation (FOXC2, SATB2, DLX5, RUNX2) [20, 21]. 
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4. Discussion 
The vast majority of the in vitro experimentally documented transcriptional regulatory effects 
of ubiquitously distributed and /or generally important gene regulators (GR, SMAD4 and 
CREB1) could be reproduced in bone biopsies as highly significant associations between 
transcription factor mRNAs and mRNAs of regulated genes, and were reproduced in male 
vertebral biopsies. The reference studies were performed in bone unrelated tissue and in cell 
cultures, thus giving a general validity to the results [13-15].     
 In the replication set we found a very high similarity between the direction in 
correlations between male spine and female iliac biopsies. Of 38 significant correlations in 
males (sum of Tables 1 - 3), only 1 showed inverse correlation as compared to the situation in 
females.   
We found that some of the giant matrix correlations were inversely correlated when 
compared to the published experimental data (Table 1, 2 and 3). However, this is not 
altogether surprising given the complex nature of the cell milleu of trabecular bone in terms of 
variety of cell types at various stages of differentiation, and known paradoxical action of 
growth factors and hormones. This may indicate cell or tissue specific transcriptional 
regulation due to use of different in vivo/in vitro systems. This suggestion is supported by our 
finding from similar blood mRNA correlation studies using global gene expression analysis, 
in which several genes showed inverse correlations compared to the ones described in Table 
1, 2 and 3 (not shown). It is hardly surprising that gene induction or repression as the net 
effect of binding of a TF to DNA and/or protein-protein interactions may depend on cell type 
and/or cell differentiation state. The dual functions of TFs as repressor or activator for the 
same gene have in fact been shown experimentally e.g. for the Drosophila homeodomain 
proteins, Vnd [22], and NkX6 [23]. The contextual interactions determine whether they act as 
repressors or activators. Also the estrogen receptor α can function as activator or repressor 
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depending on differential splicing [24]. The data presented in this paper indicate that GR, 
SMAD4 and CREB1 may also have dual function.  
Identification of GREs in 22 out of the top 50 GR correlated genes (Supplementary 
Table S1) is in agreement with a recent study [25] combining identification of genome wide 
GR binding elements with identification of dexamethasone induced transcripts in A549 cells. 
The study revealed that 62% of dexamethasone-induced GR binding sites contain GRE [25]. 
GR makes heterodimers with other TFs, e.g. those binding to AP-1 sites, and thereby by 
protein-protein interaction indirectly provide DNA binding for the GR [26], thus explaining 
while not all GR binding promoters contain GREs.      
 Like the GR, also SMAD4 can indirectly bind to DNA. SMAD4 can bind through its 
DNA-binding R-SMAD partner and/or other TFs like RUNX2 or Schnurri [27], thereby 
providing a plausible explanation why some sites were not picked up in the reference study 
[14]. 
Some regulatory interactions found in cell based systems could not be reproduced as 
significant p-values in the matrix, possibly due to transcriptional regulators or 
posttranslational modifications present or not present within the human bone biopsies. Thus, 
the present data also show the necessity to study human bone tissue for understanding species 
specific gene transcription and macromolecular interactions leading to specific physiological 
and pathophysiological system effects.   
Fig. 1, identifying transcripts of genes most significantly correlated to SOST mRNA as 
genes that are known to be of crucial importance for bone metabolism, should indicate that 
significant correlating transcripts represent a snapshot of the human bone gene interactome at 
the transcript level. 
 Our results from female iliac bone, and confirmed in male vertebrae demonstrate that a 
global transcriptional correlation matrix, combined with an easy-access browser application, 
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should be generally useful as a first identification of candidate interacting genes in bone, and 
in fact be of relevance in both genders. In conclusion, we have demonstrated that the in silico 
browser is useful to refine microchips data through correlations to experimental results and 
thus discover important macromolecular interactions in human bone. 
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Figure legend 
Fig. 1. Interphase of the correlation browser. A typical search starts with inserting an 
identifier in the first window of  “search option”, either EntrezGene ID (e.g. "1234"), an 
Accession Number (e.g. "BE644809" or "NM_005715"), a Gene Symbol (e.g. "SOST1" or 
"DKK1", not case-sensitive) or an Affymetrix probeset ID (e.g. "1562529_s_at"). Then, a 
specific transcript can be searched for by inserting a second identifier in the second window 
under “search option”. Alternatively, the window may be left open to obtain a list of the 
transcripts most significantly correlating to the identifier in the first window. Filling in boxes 
in the “output options” fields enable restriction of output to e.g. transcripts having specific 
keywords in Gene ontologies (GO), TFs (genes having “transcription” as part of the Gene 
Title) or only positive or negative correlations.
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Tables 
Table 1. Correlations of Glucocorticoid receptor (NR3C1) mRNA with Glucocorticoid receptor 
regulated transcripts expressed in bone biopsies 
Gene symbol  Name 
Iliac biopsies 
(n=84) 
Vertebral 
biopsies 
(n=13) 
r p P
#
 r p 
PDE4B  phosphodiesterase 4B, cAMP-specific 0.80* 6.2E-20 5.0E-19 0.68* 9.8E-03 
SDPR serum deprivation response 0.69 2.3E-13 1.9E-12 0.38 2.0E-01 
FGD4  FYVE, RhoGEF and PH domain containing 4 0.63 1.3E-10 1.1E-09 NA NA 
AMIGO2  adhesion molecule with Ig-like domain 2 0.62* 1.3E-9 1.3E-09 0.70* 7.5E-03 
C19orf42 (Stomatin) chromosome 19 open reading frame 42 0.60 1.7E-9 4.2E-08 0.79 1.3E-03 
FKBP5  FK506 binding protein 5 0.59 2.7E-9 2.2E-08 0.72 5.6E-03 
S100P  S100 calcium binding protein P -0.56* 3.3E-8 1.3E-07 -0.75* 3.0E-03 
CPEB4  cytoplasmic polyadenylation element binding protein 4 -0.55* 6.5E-8 1.0E0-6 -0.40* 1.8E-01 
ARRDC3 (KIAA1376) arrestin domain containing 3 0.53* 2.8E-7 1.1E-06 0.54* 5.6E-02 
CXCR7 (RDC1) chemokine (C-X-C motif) receptor 7 0.52* 3.5E-7 1.4E-06 0.83* 4.0E-04 
CDC42EP3  CDC42 effector protein (Rho GTPase binding) 3 0.52 4.0E-7 4.7E-06 0.66 1.4E-02 
SLC19A2  solute carrier family 19 (thiamine transporter), member 2 0.52 5.0E-7 2.0E-06 0.04 9.0E-01 
TGFBR3  transforming growth factor, beta receptor III 0.50 1.4E-6 1.1E-05 0.57 4.4E-02 
AKAP13  A kinase (PRKA) anchor protein 13 -0.47* 6.0E-6 1.7E-04 0.39 1.9E-01 
GADD45b  growth arrest and DNA-damage-inducible, beta -0.46* 8.9E-6 1.1E-04 -0.30* 3.2E-01 
CDKN1C (Kip2/p57) cyclin-dependent kinase inhibitor 1C (p57, Kip2) 0.46 1.1E-5 1.3E-04 0.81 8.0E-04 
IRS2  insulin receptor substrate 2 0.46 1.4E-5 1.1E-04 0.45 1.2E-01 
DNAJC15 (MCJ) DnaJ (Hsp40) homolog, subfamily C, member 15 0.46 1.4E-5 1.1E-04 0.76 2.8E-03 
SERPINB9(CAP3/IP9) serpin peptidase inhibitor, clade B (ovalbumin), member 9 0.45* 1.7E-5 1.4E-04 0.14* 6.5E-01 
PMP22 (PMP2) peripheral myelin protein 22 0.45* 1.7E-5 6.7E-05 0.85* 2.0E-04 
 TSC22D3 (GILZ) TSC22 domain family, member 3 0.40 2.0E-4 7.9E-04 0.46 1.1E-01 
ABHD2  abhydrolase domain containing 2 -0.39* 2.3E-4 5.5E-03 -0.46* 1.1E-01 
EPB41L4B (EHM2) erythrocyte membrane protein band 4.1 like 4B 0.38 3.4E-4 2.7E-03 0.35 2.5E-01 
GEM  GTP binding protein overexpressed in skeletal muscle 0.37* 5.3E-4 2.1E-03 0.53* 6.4E-02 
MT1X (MT-1I) metallothionein 1X 0.35 1.2E-3 9.7E-03 0.57 4.2E-02 
ENC1  ectodermal-neural cortex 1 (with BTB-like domain) 0.30* 1.9E-3 7.5E-03 0.63* 2.0E-02 
BHLHE40 (BHLHB2) basic helix-loop-helix family, member e40 0.33* 2.3E-3 9.1E-03 0.68* 1.1E-02 
PRRG4 (TMG4) proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) 0.32 3.0E-3 2.4E-02 0.06 8.3E-01 
PLK2 (SNK) polo-like kinase 2 0.31* 4.7E-3 1.9E-02 0.71* 6.8E-03 
THBD Thrombomodulin 0.30 5.7E-3 2.3E-02 0.66 1.5E-02 
B3GNT5  UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 0.29 1.9E-3 3.2E-02 -0.58* 4.0E-02 
SEC14L1  SEC14-like 1 (S. cerevisiae) -0.30* 6.3E-3 7.5E-02 -0.54* 5.4E-02 
TNFAIP3  tumor necrosis factor, alpha-induced protein 3 0.28 9.0E-3 7.2E-02 0.40 1.8E-01 
SLC26A2  solute carrier family 26 (sulfate transporter), member 2 -0.28* 1.1E-2 1.3E-01 0.23 4.5E-01 
MGAM  maltase-glucoamylase (alpha-glucosidase) -0.23* 3.5E-2 1.4E-01 -0.49* 8.9E-02 
RGS2  regulator of G-protein signaling 2, 24kDa -0.22* 4.0E-2 1.6E-01 -0.32* 2.9E-01 
FLVCR2 (FLJ20371) feline leukemia virus subgroup C cellular receptor family, member 2 0.22 4.9E-2 2.0E-01 0.15 6.3E-01 
LRRC8A (LRRC8) leucine rich repeat containing 8 family, member A -0.20* 6.9E-2 2.7E-01 0.07 8.3E-01 
PTGS2 (COX-2, CG1/XP28) prostaglandin-endoperoxide synthase 2 0.11* 3.3E-1 1.3E+0
0 
0.11* 7.2E-01 
CCL2  chemokine (C-C motif) ligand 2 -0.08 4.6E-1 1.9E+0
0 
0.01* 9.7E-01 
“*” Inverse correlations as compared to regulation in the reference study [13]. Parentheses denotes 
synonymous gene names used in the reference study. In cases where multiple probesets represent the same 
gene, only the most significant correlation is shown. Identical probesets were compared in the main and 
replica studies. Shaded cells represent significant (p or p
#
 <0.05) correlations. p
#
: Bonferroni corrected p-
values. NA: not applicable (undetected in the dataset) 
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Table 2.  Correlations of SMAD4 mRNA with SMAD4 regulated transcripts expressed in bone 
biopsies 
Gene 
symbol  
Name 
Iliac biopsies 
(n=84) 
Vertebral 
biopsies 
(n=13) 
r p p
#
 r p 
CSNK1A1 casein kinase 1, alpha 1 0.81 6.3E-21 2.1E-19 0.83 5.0E-04 
STK38L serine/threonine kinase 38 like 0.75 1.4E-16 8.3E-16 0.62 2.3E-02 
UBE2D3 ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) 0.73 4.4E-15 5.3E-14 0.35 2.4E-01 
C6orf62 chromosome 6 open reading frame 62 0.71 7.0E-14 8.3E-13 0.66 1.5E-02 
GPHN Gephyrin 0.66* 5.7E-12 3.4E-11 0.71* 6.3E-03 
SRPK2 SFRS protein kinase 2 0.64 5.4E-11 6.5E-10 0.42 1.5E-01 
ARHGAP5 Rho GTPase activating protein 5 0.63 1.6E-10 1.5E-09 0.78 1.6E-03 
NFAT5 nuclear factor of activated T-cells 5, tonicity-responsive 0.60 2.1E-09 1.3E-08 0.36 2.3E-01 
ZNF638 zinc finger protein 638 0.60 1.3E-09 1.9E-08 0.61 2.6E-02 
PPP4R2 protein phosphatase 4, regulatory subunit 2 0.59 4.1E-09 2.5E-08 0.45 1.3E-01 
HERC1 hect domain and RCC1 (CHC1) 0.57 1.3E-08 3.8E-08 0.28 3.6E-01 
MTUS1 microtubule associated tumor suppressor 1 0.58* 1.1E-08 6.3E-08 0.75* 3.2E-03 
FNTB Farnesyltransferase, CAAX box, beta 0.56 2.5E-08 1.5E-07 0.70 7.9E-03 
KLF9 Kruppel-like factor 9 0.56* 3.1E-08 1.8E-07 0.53* 6.1E-02 
ARL2BP ADP-ribosylation factor-like 2 binding protein 0.52 3.9E-07 1.2E-06 0.82 6.0E-04 
BDNF brain-derived neurotrophic factor -0.46 9.2E-06 2.8E-05 NA NA 
KLF12 Kruppel-like factor 12 0.48* 5.0E-06 3.0E-05 0.70* 7.7E-03 
TGFBR2 transforming growth factor, beta receptor II (70/80kDa) 0.45* 1.4E-05 4.2E-05 0.26* 3.8E-01 
IL1B interleukin 1, beta 0.43 4.6E-05 1.4E-04 0.26 3.9E-01 
GTF2H2 general transcription factor IIH, polypeptide 2, 44kDa 0.43 4.8E-05 1.4E-04 0.29 3.4E-01 
PELI2 pellino homolog 2 (Drosophila) 0.42 5.8E-05 1.7E-04 0.75 3.0E-03 
FBXO32 F-box protein 32 0.43 3.8E-05 2.3E-04 0.58 3.7E-02 
LTBP2 latent transforming growth factor beta binding protein 2 0.43 5.3E-05 3.2E-04 0.30 3.1E-01 
MICAL2 microtubule associated monoxygenase, calponin and LIM domain containing 2 -0.42* 7.3E-05 4.4E-04 -0.48* 9.6E-02 
ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 0.40 1.7E-04 5.0E-04 0.28 3.5E-01 
SOX4 SRY (sex determining region Y)-box 4 0.39 2.7E-04 8.0E-04 0.49 9.1E-02 
TTC14 tetratricopeptide repeat domain 14 -0.40* 1.6E-04 9.8E-04 -0.22* 4.8E-01 
SYTL2 synaptotagmin-like 2 0.39* 2.2E-04 1.3E-03 0.73* 4.4E-03 
TNFSF13B tumor necrosis factor (ligand) superfamily, member 13b -0.37 4.6E-04 2.7E-03 -0.30 3.2E-01 
DMBT1 deleted in malignant brain tumors 1 -0.35 1.2E-03 3.7E-03 -0.23 4.6E-01 
SMAD3 SMAD family member 3 0.30* 5.1E-03 1.5E-02 0.89* 2.3E-04 
PREX1 phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 0.31* 3.7E-03 2.2E-02 0.35* 2.4E-01 
SP110 SP110 nuclear body protein 0.34* 1.5E-03 2.3E-02 0.36* 2.2E-01 
TNC Tenascin C 0.31 4.0E-03 2.4E-02 0.05 8.6E-01 
DNM3 dynamin 3 -0.30* 4.8E-03 2.9E-02 0.22 4.8E-01 
UGDH UDP-glucose 6-dehydrogenase 0.28 1.1E-02 3.2E-02 0.59 3.5E-02 
LRRC20 leucine rich repeat containing 20 0.27* 1.2E-02 3.5E-02 0.31* 3.0E-01 
NASP nuclear autoantigenic sperm protein (histone-binding) -0.30* 5.3E-03 4.8E-02 0.41 1.6E-01 
STARD4 StAR-related lipid transfer (START) domain containing 4 0.25 2.4E-02 7.1E-02 0.78 1.7E-03 
ABAT 4-aminobutyrate aminotransferase 0.26 1.9E-02 1.1E-01 0.25 4.1E-01 
EPB41L4B erythrocyte membrane protein band 4.1 like 4B 0.24* 2.5E-02 1.5E-01 NA NA 
OAS1 2',5'-oligoadenylate synthetase 1, 40/46kDa 0.24* 2.6E-02 1.6E-01 -0.22 4.8E-01 
APOL6 apolipoprotein L, 6 0.20* 6.2E-02 1.9E-01 0.50* 8.1E-02 
MSN Moesin -0.18* 9.9E-02 3.0E-01 -0.22* 4.6E-01 
C6orf105 chromosome 6 open reading frame 105 0.15 1.7E-01 5.0E-01 0.01 9.7E-01 
EPSTI1 epithelial stromal interaction 1 (breast) -0.18 9.6E-02 5.8E-01 0.17* 5.8E-01 
SEMA4B sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) 
and short cyt 
-0.06 5.8E-01 1.7E+00 -0.36 2.2E-01 
“*” Inverse correlations as compared to regulation in the reference study [14]. In cases where multiple 
probesets represent the same gene, only the most significant correlation is shown. Identical probesets were 
compared in the main and replica studies. Shaded cells represent significant (p or p
#
 <0.05) correlations. 
p
#
: Bonferroni corrected p-values NA: not applicable (undetected in the dataset) 
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 Table 3.  Correlations of CREB1 mRNA with forskolin regulated transcripts expressed in bone biopsies 
Gene symbol  Name 
Iliac biopsies 
(n=84) 
Vertebral 
biopsies 
(n=13) 
r p p
#
 r p 
GSK3B (GSK3β) glycogen synthase kinase 3 beta 0.79 2.78E-19 5.85E-18 0.88 2.5E-05 
MAT2A (MAT IIA) methionine adenosyltransferase II, alpha 0.75 1.37E-16 2.87E-15 0.94 5.0E-05 
PSEN1 (presenilin-1) presenilin 1 0.75 1.78E-16 4.98E-15 0.96 2.5E-05 
CiRBP cold inducible RNA binding protein -0.69* 2.36E-13 8.25E-12 -0.54* 5.7E-02 
AZIN1 (Oazi) antizyme inhibitor 1 0.68 8.21E-13 1.15E-11 0.65 1.7E-02 
ARRB1 (β arrestin 1) arrestin, beta 1 -0.59* 2.50E-09 3.50E-08 -0.53* 6.4E-02 
JUND (JunD) jun D proto-oncogene -0.57* 1.48E-08 1.03E-07 -0.07* 8.2E-01 
MAF (c-maf) v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) 0.55 5.81E-08 1.22E-06 0.03 9.2E-01 
NUP98 (Nup98) nucleoporin 98kDa 0.51 5.81E-07 1.22E-05 0.87 3.9 E-04 
PPP1R15A (Myd116) protein phosphatase 1, regulatory (inhibitor) subunit 15A -0.45* 1.96E-05 2.75E-04 0.04 8.9E-01 
BMP2 bone morphogenetic protein 2 0.44 2.25E-05 3.15E-04 0.45 1.3E-01 
EGLN1 (Egl 9 homolog) egl nine homolog 1 -0.43* 3.71E-05 7.78E-04 -0.25* 4.2E-01 
Id3 inhibitor of DNA binding 3 -0.43* 3.84E-05 2.69E-04 -0.49* 8.8E-02 
MEF2D (Mef2D) myocyte enhancer factor 2D 0.43 3.89E-05 2.72E-04 -0.35* 2.4E-01 
NDEL1 (Nudel) nudE nuclear distribution gene E homolog (A. nidulans)-like 1 0.42 6.63E-05 4.64E-04 -0.29* 3.4E-01 
TUBB3 (βIII tubulin) tubulin, beta 3 -0.42* 7.25E-05 1.02E-03 0.22 8.9E-01 
Hes1 hairy and enhancer of split 1, (Drosophila) -0.42* 7.90E-05 1.11E-03 -0.24* 4.4E-01 
Pim1 pim-1 oncogene 0.41 1.07E-04 7.49E-04 0.15 6.2E-01 
JunB jun B proto-oncogene -0.40* 1.38E-04 9.67E-04 -0.07* 8.1E-01 
VEGFA (VEGF) vascular endothelial growth factor A 0.40 1.43E-04 2.00E-03 0.16 6.1E-01 
EGR1 early growth response 1 -0.40* 1.82E-04 3.82E-03 0.47 1.1E-01 
CAV1 (Caveolin) caveolin 1, caveolae protein, 22kDa -0.39* 2.36E-04 3.30E-03 0.09 7.7E-01 
NFIL3 (Nfil3) nuclear factor, interleukin 3 regulated 0.39 2.50E-04 1.75E-03 0.42 1.5E-01 
Dyrk1a dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A 0.39 2.95E-04 2.07E-03 0.49 8.7E-02 
RhoB ras homolog gene family, member B -0.38* 3.03E-04 2.12E-03 -0.27* 3.7E-01 
Id2 inhibitor of DNA binding 2 0.37 4.73E-04 6.62E-03 0.36 2.3E-01 
DLGAP4 (DAP-4) discs, large (Drosophila) homolog-associated protein 4 0.34 1.49E-03 3.13E-02 -0.36* 2.3E-01 
IRS1 insulin receptor substrate 1 -0.34* 1.61E-03 1.12E-02 -0.13* 6.7E-01 
CEBPB (C/EBPβ) CCAAT/enhancer binding protein (C/EBP), beta -0.34* 1.74E-03 1.22E-02 -0.19* 5.4E-01 
PER1 (Per1) period homolog 1 (Drosophila) -0.33* 2.22E-03 1.55E-02 0.25 4.1E-01 
KLF10 (TIEG1) Kruppel-like factor 10 0.32 2.79E-03 1.95E-02 0.38 4.7E-01 
PDE4D phosphodiesterase 4D, cAMP-specific 0.31 3.72E-03 7.81E-02 0.38 2.0E-01 
BHLHE40 (Bhlhb2) basic helix-loop-helix family, member e40 -0.31* 4.53E-03 3.17E-02 -0.32* 2.8E-01 
ID1 (Id1) inhibitor of DNA binding 1 -0.29* 6.55E-03 4.58E-02 -0.49* 8.8E-02 
DUSP10 (MKP5) dual specificity phosphatase 10 0.27 1.16E-02 8.13E-02 0.44 1.3E-01 
KLF4 (Klf4) Kruppel-like factor 4 (gut) -0.27* 1.18E-02 8.23E-02 0.37 2.2E-01 
FOS (c-fos) FBJ murine osteosarcoma viral oncogene homolog -0.25* 2.29E-02 1.60E-01 -0.15* 6.3E-01 
BTG2 (Btg2) BTG family, member 2 -0.12* 2.97E-01 2.08E+00 0.16 6.0E-01 
“*” Inverse correlations as compared to regulation in the reference study [15]. In cases where multiple 
probesets represent the same gene, only the most significant correlation is shown. Identical probesets were 
compared in the main and replica studies. Shaded cells represent significant (p or p
#
 <0.05) correlations. p
#
: 
Bonferroni corrected p-values 
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